scispace - formally typeset
A

Alaa Alashi

Researcher at Cleveland Clinic

Publications -  46
Citations -  4559

Alaa Alashi is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Medicine. The author has an hindex of 13, co-authored 39 publications receiving 2672 citations. Previous affiliations of Alaa Alashi include Texas Tech University Health Sciences Center at El Paso & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

Jeffrey D. Stanaway, +1053 more
- 10 Nov 2018 - 
TL;DR: This study estimated levels and trends in exposure, attributable deaths, and attributable disability-adjusted life-years (DALYs) by age group, sex, year, and location for 84 behavioural, environmental and occupational, and metabolic risks or groups of risks from 1990 to 2017 and explored the relationship between development and risk exposure.
Journal ArticleDOI

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

Evangelos Oikonomou, +23 more
- 15 Sep 2018 - 
TL;DR: The perivascular FAI enhances cardiac risk prediction and restratification over and above current state-of-the-art assessment in coronary CTA by providing a quantitative measure of coronary inflammation.
Journal ArticleDOI

A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography

Evangelos Oikonomou, +33 more
- 14 Nov 2019 - 
TL;DR: The CCTA-based radiomic profiling of coronary artery PVAT detects perivascular structural remodelling associated with coronary artery disease, beyond inflammation and leads to a striking improvement of cardiac risk prediction over and above the current state-of-the-art.
Journal ArticleDOI

Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017

Simon Yadgir, +80 more
- 26 May 2020 - 
TL;DR: These global and national estimates demonstrate that CAVD and degenerative mitral valve disease are important causes of disease burden among older adults, with highest age-standardized DALY rates of CAVD estimated for high-income countries.
Journal ArticleDOI

Long-Term Outcomes in Patients With Aortic Regurgitation and Preserved Left Ventricular Ejection Fraction

Amgad Mentias, +10 more
- 15 Nov 2016 - 
TL;DR: At a high-volume experienced center, patients with grade III or greater AR and preserved LVEF demonstrated significantly improved long-term survival following AV surgery, and the risk of death significantly increased at a lower LV dimension threshold than previously described.